BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14986267)

  • 1. Clinical significance of Streptococcus pneumoniae resistance reporting remains confusing.
    Siegel RE
    Clin Infect Dis; 2004 Mar; 38(5):764-5; author reply 765-6. PubMed ID: 14986267
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
    Low DE
    Clin Infect Dis; 2004 May; 38 Suppl 4():S357-62. PubMed ID: 15127370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.
    Pérez-Trallero E; Marimón JM; González A; Ercibengoa M; Larruskain J
    Clin Infect Dis; 2005 Aug; 41(4):560-4. PubMed ID: 16028169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
    Le Hello S; Page S; Garin B
    Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
    [No Abstract]   [Full Text] [Related]  

  • 5. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD
    Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in pneumococcal susceptibility to azithromycin during treatment for acute otitis media.
    Toltzis P; Dul M; Blumer J
    Pediatr Infect Dis J; 2007 Jul; 26(7):647-9. PubMed ID: 17596812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
    Martynova AV; Turcutyuicov VB
    Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999.
    Brandileone MC; Casagrande ST; Guerra ML; Zanella RC; de Andrade AL; Di Fabio JL
    J Antimicrob Chemother; 2005 Aug; 56(2):437-9. PubMed ID: 15972313
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
    Low DE
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The public health ramifications of pneumococcal resistance.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():1-3. PubMed ID: 19366361
    [No Abstract]   [Full Text] [Related]  

  • 12. Geographic variation in penicillin resistance in Streptococcus pneumoniae: selected sites, United States, 1997.
    Paterick BD; Pollack CV
    Ann Emerg Med; 2000 May; 35(5):506-8. PubMed ID: 10783413
    [No Abstract]   [Full Text] [Related]  

  • 13. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
    Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Yokota S; Ohkoshi Y; Fujii N
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract]   [Full Text] [Related]  

  • 16. [Invasive disease caused by Streptococcus pneumoniae: serotypes and antimicrobial susceptibility in a Health Care Area in Galicia].
    Sánchez FP; Bernal ML; Jung PA; Lamas LM; García BR
    Rev Esp Quimioter; 2007 Dec; 20(4):421-8. PubMed ID: 18563215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality.
    Yu VL; Baddour LM
    Clin Infect Dis; 2004 Oct; 39(7):1086-7; author reply 1087-8. PubMed ID: 15472872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of the antibiogram in Streptococcus pneumoniae (pneumococcal) infections].
    Modde H
    Rev Med Suisse Romande; 1980 Sep; 100(9):805-8. PubMed ID: 6906046
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotypes and antimicrobial resistance of streptococcus pneumoniae in Thailand 2002-2004.
    Levine S; Dejsirilert S; Sangsuk L; Chantra S; Feikin DR; Dowell SF; Olsen SJ
    Pediatr Infect Dis J; 2006 Feb; 25(2):176-8. PubMed ID: 16462300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.